Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia
Authors:
Open Access
- 9 April 2012
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 26 (11) , 2303-2309
Abstract
Hypersensitivity to asparaginase is common, but the differential diagnosis can be challenging and the diagnostic utility of antibody tests is unclear. We studied allergic reactions and serum antibodies to E. coli asparaginase (Elspar) in 410 children treated on St. Jude Total XV protocol for acute lymphoblastic leukemia. Of 169 patients (41.2%) with clinical allergy, 147 (87.0%) were positive for anti-Elspar antibody. Of 241 patients without allergy, 89 (36.9%) had detectable antibody. Allergies (P=0.0002) and antibodies (P=6.6 × 10−6) were higher among patients treated on the low-risk arm than among those treated on the standard/high-risk arm. Among those positive for antibody, the antibody titers were higher in those who developed allergy than in those who did not (P−15). Antibody measures at week 7 of continuation therapy had a sensitivity of 87–88% and a specificity of 68–69% for predicting or confirming clinical reactions. The level of antibodies was inversely associated with serum asparaginase activity (P=7.0 × 10−6). High antibody levels were associated with a lower risk of osteonecrosis (odds ratio=0.83; 95% confidence interval, 0.78–0.89; P=0.007). Antibodies were related to clinical allergy and to low systemic exposure to asparaginase, leading to lower risk of some adverse effects of therapy.Keywords
This publication has 42 references indexed in Scilit:
- Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemiaBlood, 2012
- Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemiaBlood, 2011
- Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemiaNature Genetics, 2011
- Genetic Variations in GRIA1 on Chromosome 5q33 Related to Asparaginase HypersensitivityClinical Pharmacology & Therapeutics, 2010
- Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemiaPediatric Blood & Cancer, 2009
- Treating Childhood Acute Lymphoblastic Leukemia without Cranial IrradiationNew England Journal of Medicine, 2009
- A mouse model for glucocorticoid‐induced osteonecrosis: Effect of a steroid holidayJournal of Orthopaedic Research, 2008
- Osteonecrosis in children and adolescents with cancer – An adverse effect of systemic therapyEuropean Journal of Cancer, 2007
- Osteonecrosis of vertebrae in a child with acute lymphocytic leukaemia duringl-asparaginase therapyEuropean Journal of Pediatrics, 1989
- Four-Agent Induction and Intensive Asparaginase Therapy for Treatment of Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1986